3.12.2009   

EN

Official Journal of the European Union

L 317/36

(1)

Decision 2009/470/EC lays down the procedures governing the Community’s financial contribution for programmes for the eradication, control and monitoring of animal diseases and zoonoses.

(2)

In addition, Article 27(1) of Decision 2009/470/EC provides that a Community financial measure is to be introduced to reimburse the expenditure incurred by the Member States for the financing of national programmes for the eradication, control and monitoring of the animal diseases and zoonoses listed in the Annex to that Decision.

(3)

Council Decision 2006/965/EC of 19 December 2006 amending Decision 90/424/EEC on expenditure in the veterinary field (2) replaced Article 24 to that Decision by a new provision. By way of transitional measures, Decision 2006/965/EC provided that programmes for enzootic bovine leucosis and for Aujeszky’s disease could continue to be funded until 31 December 2010.

(4)

Commission Decision 2008/341/EC of 25 April 2008 laying down Community criteria for national programmes for the eradication, control and monitoring of certain animal diseases and zoonoses (3) provides that in order to be approved under the measures provided for in Article 27(1) of Decision 2009/470/EC, programmes submitted by the Member States must meet the criteria set out in the Annex to Decision 2008/341/EC.

(5)

Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (4), provides for annual monitoring programmes by Member States for transmissible spongiform encephalopathies (TSEs) in bovine, ovine and caprine animals.

(6)

Council Directive 2005/94/EC of 20 December 2005 on Community measures for the control of avian influenza (5) also provides for surveillance programmes by Member States to be carried out in respect of poultry and wild birds in order to contribute, inter alia, on the basis of regularly updated risk-assessments, to the knowledge on the threats posed by the wild birds in relation to any influenza virus of avian origin in birds. Those annual programmes, and their financing, for monitoring should also be approved.

(7)

Certain Member States have submitted to the Commission annual programmes for the eradication, control and monitoring of animal diseases, programmes of checks aimed at the prevention of zoonoses, and annual monitoring programmes for the eradication and monitoring of certain TSEs for which they wish to receive a financial contribution from the Community.

(8)

In 2008 and 2009 certain multi-annual programmes submitted by Member States for the eradication, control and monitoring of the animal diseases were approved under Commission Decision 2007/782/EC (6) and Commission Decision 2008/897/EC (7). The commitment of the expenditure for those multi-annual programmes was adopted in accordance with Article 76(3) of Council Regulation (EC, Euratom) No 1605/2002 of 25 June 2002 on the Financial Regulation applicable to the general budget of the European Union (8). The first budget commitment for those programmes was made after their approval. Each subsequent annual commitment should be made by the Commission in function of the execution of the programme for the previous year, on the basis of a decision to grant a contribution referred to in Article 27(5) of Decision 2009/470/EC.

(9)

Regulation (EC) No 999/2001, as amended by Commission Regulation (EC) No 103/2009 (9), provides for more stringent requirements to be complied with in the case of milk producing flocks infected with classical scrapie.

(10)

In 2009 Cyprus submitted a multi-annual, programme for the monitoring and eradication of scrapie, adapted to that recent amendment of Regulation (EC) No 999/2001. Commission Decision No 2009/560/EC (10), approved the multi-annual scrapie programme where the cost of personnel specifically hired for carrying out tasks within the programme and the cost of destroying the carcasses was included in the costs eligible for a Community financial contribution. The second and last year of the multi-annual scrapie programme submitted by Cyprus should therefore be approved and provide for the same level of Community financing and eligible measures as for the first year.

(11)

The Commission has assessed the annual programmes submitted by the Member States, as well as the subsequent year (second or third) of the multi-annual programmes approved in 2008 and 2009, from both the veterinary and the financial point of view. Those programmes were found to comply with relevant Community veterinary legislation and in particular with the criteria set out in Decision 2008/341/EC.

(12)

In the light of the importance of the annual and multi-annual programmes for the achievement of Community objectives in the field of animal and public health, as well as the obligatory application in all Member States in the case of the TSE and avian influenza programmes, it is appropriate to fix the appropriate rate of financial contribution of the Community to reimburse the costs to be incurred by the Member States concerned for the measures referred to in this Decision up to a maximum amount for each programme.

(13)

For the sake of better management, more efficient use of Community funds and improved transparency, it is also necessary to fix for each programme, where appropriate, average cost to be reimbursed to the Member States for certain costs, such as the tests used in the Member States and compensation to owners for their losses due to the slaughter or culling of animals.

(14)

Under Council Regulation (EC) No 1290/2005 of 21 June 2005 on the financing of the common agricultural policy (11), programmes for the eradication and control of animal diseases are to be financed under the European Agricultural Guarantee Fund. For financial control purposes, Articles 9, 36 and 37 of that Regulation are to apply.

(15)

The financial contribution from the Community should be granted subject to the condition that the actions planned are efficiently carried out and that the competent authorities supply all the necessary information within the time limits laid down in this Decision.

(16)

For reasons of administrative efficiency all expenditure submitted for a financial contribution by the Community should be expressed in Euro. In accordance with Regulation (EC) No 1290/2005, the conversion rate for expenditure in a currency other than the Euro should be the most recent exchange rate set by the European Central Bank prior to the first day of the month in which the application is submitted by the Member State concerned.

(17)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

(a)

EUR 2 000 000 for Spain;

(b)

EUR 5 000 000 for Italy;

(c)

EUR 75 000 for Cyprus;

(d)

EUR 15 000 for Malta;

(e)

EUR 2 500 000 for Portugal;

(f)

EUR 2 700 000 for the United Kingdom.

(a)

for a rose bengal test

EUR 0,2 per test;

(b)

for a SAT test

EUR 0,2 per test;

(c)

for a complement fixation test

EUR 0,4 per test;

(d)

for an ELISA test

EUR 1 per test;

(e)

for animals slaughtered

EUR 375 per animal.

(a)

EUR 12 000 000 for Ireland;

(b)

EUR 7 500 000 for Spain;

(c)

EUR 4 000 000 for Italy;

(d)

EUR 1 000 000 for Portugal;

(e)

EUR 10 000 000 for the United Kingdom.

(a)

for a tuberculin test

EUR 1,75 per test;

(b)

for a gamma-interferon test

EUR 5 per test;

(c)

for animals slaughtered

EUR 375 per animal.

(a)

EUR 4 500 000 for Spain;

(b)

EUR 3 500 000 for Italy;

(c)

EUR 75 000 for Cyprus;

(d)

EUR 1 100 000 for Portugal.

(a)

for a rose bengal test

EUR 0,2 per test;

(b)

for a complement fixation test

EUR 0,4 per test;

(c)

for animals slaughtered

EUR 50 per animal.

(a)

EUR 4 500 000 for Belgium;

(b)

EUR 6 000 for Bulgaria;

(c)

EUR 1 600 000 for the Czech Republic;

(d)

EUR 50 000 for Denmark;

(e)

EUR 16 800 000 for Germany;

(f)

EUR 130 000 for Estonia;

(g)

EUR 80 000 for Ireland;

(h)

EUR 70 000 for Greece;

(i)

EUR 20 000 000 for Spain;

(j)

EUR 40 000 000 for France;

(k)

EUR 2 700 000 for Italy;

(l)

EUR 310 000 for Latvia;

(m)

EUR 630 000 for Lithuania;

(n)

EUR 300 000 for Luxembourg;

(o)

EUR 780 000 for Hungary;

(p)

EUR 4 000 for Malta;

(q)

EUR 110 000 for the Netherlands;

(r)

EUR 1 000 000 for Austria;

(s)

EUR 70 000 for Poland;

(t)

EUR 5 200 000 for Portugal;

(u)

EUR 110 000 for Romania;

(v)

EUR 590 000 for Slovenia;

(w)

EUR 50 000 for Slovakia;

(x)

EUR 490 000 for Finland;

(y)

EUR 1 700 000 for Sweden.

(a)

(b)

(c)

(d)

(e)

for the administration of vaccines to bovine animals EUR 1,50 per bovine animal vaccinated, regardless of the number and types of doses used;

(f)

for the administration of vaccines to ovine or caprine animals EUR 0,75 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.

(a)

EUR 2 000 000 for Belgium;

(b)

EUR 20 000 for Bulgaria;

(c)

EUR 2 500 000 for the Czech Republic;

(d)

EUR 200 000 for Denmark;

(e)

EUR 15 000 for Estonia;

(f)

EUR 800 000 for Germany;

(g)

EUR 100 000 for Ireland;

(h)

EUR 550 000 for Greece;

(i)

EUR 2 500 000 for Spain;

(j)

EUR 3 500 000 for France;

(k)

EUR 1 250 000 for Italy;

(l)

EUR 100 000 for Cyprus;

(m)

EUR 420 000 for Latvia;

(n)

EUR 160 000 for Lithuania;

(o)

EUR 10 000 for Luxembourg;

(p)

EUR 2 500 000 for Hungary;

(q)

EUR 150 000 for Malta;

(r)

EUR 3 500 000 for the Netherlands;

(s)

EUR 960 000 for Austria;

(t)

EUR 3 500 000 for Poland;

(u)

EUR 255 000 for Portugal;

(v)

EUR 600 000 for Romania;

(w)

EUR 117 000 for Slovenia;

(x)

EUR 730 000 for Slovakia;

(y)

EUR 52 000 for the United Kingdom.

(a)

for a bacteriological test (cultivation/isolation) EUR 5,0 per test;

(b)

for the purchase of Salmonella vaccine dose EUR 0,05 per dose;

(c)

for serotyping of relevant isolates of Salmonella spp. EUR 20 per test;

(d)

for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a Salmonella-positive flock EUR 5,0 per test;

(e)

for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for Salmonella EUR 5 per test;

(f)

for the compensation for the value of a parent breeding bird of Gallus gallus culled, EUR 4 per bird;

(g)

for the compensation for the value of a commercial laying bird of Gallus gallus culled, EUR 2,20 per bird;

(h)

for the compensation for the value of a parent breeding turkey bird of Meleagris gallopavo culled, EUR 12 per bird;

(i)

for the compensation for hatching eggs of parent breeding Gallus gallus, EUR 0,20 per hatching egg destroyed;

(j)

for the compensation for table eggs of Gallus gallus EUR 0,04 per table egg destroyed;

(k)

for the compensation for hatching eggs of parent breeding Meleagris gallopavo, EUR 0,40 per hatching egg destroyed;

(a)

Classical swine fever submitted by Bulgaria, Germany, France, Luxembourg, Hungary, Romania, Slovenia and Slovakia are hereby approved for the period from 1 January 2010 to 31 December 2010;

(b)

African swine fever submitted by Italy is hereby approved for the period from 1 January 2010 to 31 December 2010.

(a)

EUR 240 000 for Bulgaria;

(b)

EUR 1 400 000 for Germany;

(c)

EUR 720 000 for France;

(d)

EUR 110 000 for Italy;

(e)

EUR 25 000 for Luxembourg

(f)

EUR 300 000 for Hungary;

(g)

EUR 1 200 000 for Romania;

(h)

EUR 30 000 for Slovenia;

(i)

EUR 515 000 for Slovakia.

(a)

EUR 135 000 for Belgium;

(b)

EUR 50 000 from Bulgaria;

(c)

EUR 85 000 for the Czech Republic;

(d)

EUR 200 000 for Denmark;

(e)

EUR 350 000 for Germany;

(f)

EUR 10 000 for Estonia;

(g)

EUR 110 000 for Ireland;

(h)

EUR 70 000 for Greece;

(i)

EUR 300 000 for Spain;

(j)

EUR 250 000 for France;

(k)

EUR 650 000 for Italy;

(l)

EUR 20 000 for Cyprus;

(m)

EUR 60 000 for Latvia;

(n)

EUR for 10 000 Luxembourg;

(o)

EUR 300 000 for Hungary;

(p)

EUR 10 000 for Malta;

(q)

EUR 350 000 for the Netherlands;

(r)

EUR 55 000 for Austria;

(s)

EUR 100 000 for Poland;

(t)

EUR 200 000 for Portugal;

(u)

EUR 400 000 for Romania;

(v)

EUR 40 000 for Slovenia;

(w)

EUR 35 000 for Slovakia;

(x)

EUR 35 000 for Finland;

(y)

EUR 200 000 for Sweden;

(z)

EUR 300 000 for the United Kingdom.

(a)

ELISA test

EUR 2 per test;

(b)

agar gel immune diffusion test

EUR 1,2 per test;

(c)

HI test for H5/H7

EUR 12 per test;

(d)

virus isolation test

EUR 40 per test;

(e)

PCR test

EUR 20 per test;

(f)

sampling wild birds

EUR 20 per sample.

(a)

EUR 1 670 000 for Belgium;

(b)

EUR 720 000 for Bulgaria;

(c)

EUR 900 000 for the Czech Republic;

(d)

EUR 1 000 000 for Denmark;

(e)

EUR 7 810 000 for Germany;

(f)

EUR 200 000 for Estonia;

(g)

EUR 3 570 000 for Ireland;

(h)

EUR 2 000 000 for Greece;

(i)

EUR 5 300 000 for Spain;

(j)

EUR 12 500 000 for France;

(k)

EUR 6 000 000 for Italy;

(l)

EUR 50 000 for Cyprus;

(m)

EUR 240 000 for Latvia;

(n)

EUR 460 000 for Lithuania;

(o)

EUR 75 000 for Luxembourg;

(p)

EUR 1 150 000 for Hungary;

(q)

EUR 20 000 for Malta;

(r)

EUR 2 500 000 for the Netherlands;

(s)

EUR 1 010 000 for Austria;

(t)

EUR 3 100 000 for Poland;

(u)

EUR 1 350 000 for Portugal;

(v)

EUR 1 000 000 for Romania;

(w)

EUR 180 000 for Slovenia;

(x)

EUR 650 000 for Slovakia;

(y)

EUR 410 000 for Finland;

(z)

EUR 650 000 for Sweden;

(za)

EUR 4 700 000 for the United Kingdom.

(a)

for tests carried out in bovine animals

EUR 5 per test;

(b)

for tests carried out in ovine and caprine animals

EUR 30 per test;

(c)

for confirmatory and primary molecular discriminatory tests

EUR 175 per test;

(d)

per genotyping test

EUR 10;

(e)

per culled bovine animal

EUR 500;

(f)

per culled sheep or goat

EUR 70.

(a)

EUR 820 000 for Bulgaria;

(b)

EUR 880 000 for Hungary;

(c)

EUR 4 100 000 for Poland;

(d)

EUR 1 800 000 for Romania;

(e)

EUR 370 000 for Slovakia.

(a)

for an ELISA test

EUR 8 per test;

(b)

for a test to detect tetracycline in bone

EUR 8 per test;

(c)

for a fluorescent antibody test (FAT)

EUR 12 per test.

(a)

EUR 20 000 for Estonia;

(b)

EUR 20 000 for Lithuania;

(c)

EUR 500 000 for Malta;

(d)

EUR 1 400 000 for Poland.

(a)

for an ELISA test

EUR 0,5 per test;

(b)

for an agar gel immune diffusion test

EUR 0,5 per test;

(c)

for an animal slaughtered

EUR 375 per animal.

(a)

EUR 25 000 for Bulgaria;

(b)

EUR 122 000 for Hungary;

(c)

EUR 3 764 000 for Poland;

(d)

EUR 870 000 for Spain.

(a)

EUR 950 000 for Estonia;

(b)

EUR 1 130 000 for Latvia;

(c)

EUR 1 000 000 for Lithuania;

(d)

EUR 110 000 for Austria

(e)

EUR 550 000 for Slovenia;

(f)

EUR 100 000 for Finland.

(a)

for an ELISA test

EUR 8 per test;

(b)

for a test to detect tetracycline in bone

EUR 8 per test;

(c)

for a fluorescent antibody test (FAT)

EUR 12 per test.

(a)

EUR 800 000 for Italy;

(b)

EUR 55 000 for Latvia;

(c)

EUR 750 000 for Portugal.

(a)

for an ELISA test

EUR 0,5 per test;

(b)

for an agar gel immune diffusion test

EUR 0,5 per test;

(c)

for animals slaughtered

EUR 375 per animal.

(a)

100 % of the costs to be incurred by Cyprus for carrying out rapid tests referred to in Annex III Chapter A Part II points 1 to 5 to Regulation (EC) No 999/2001 and Annex VII thereto and primary molecular discriminatory tests as referred to in Annex X Chapter C point 3.2(c)(i) to Regulation (EC) No 999/2001;

(b)

75 % of the cost incurred by Cyprus for the compensation to owners for the value of their animals culled and destroyed in accordance with its programme for monitoring and eradication of scrapie;

(c)

50 % of the costs of:

(a)

for tests carried out in ovine and caprine animals

EUR 30 per test;

(b)

for primary molecular discriminatory tests carried out

EUR 175 per test;

(c)

for genotyping tests

EUR 10 per test;

(d)

for culled sheep or goats

EUR 100 per animal.

(a)

implement the programmes in accordance with the relevant provisions of Community law, including rules on competition and on the award of public contracts;

(b)

bring into force by 1 January 2010 at the latest the laws, regulations and administrative provisions necessary for implementing the programmes referred to in Articles 1 to 16;

(c)

forward to the Commission by 31 July 2010 at the latest the intermediate technical and financial reports for the programmes referred to in Articles 1 to 16, in accordance with Article 27(7)(a) of Decision 2009/470/EC;

(d)

for the programmes referred to in Article 8, report to the Commission the positive and negative results of investigations detected during their surveillance of poultry and wild birds through the Commission on-line system, every three months, by forwarding those results within a period of four weeks following the end of the month covered by the report;

(e)

for the programmes referred to in Articles 1 to 16, forward a final report to the Commission in accordance with Article 27(7)(b) of Decision 2009/470/EC by 30 April 2011 at the latest on the technical execution of the programme accompanied by justifying evidence as to the costs paid by the Member State and the results attained during the period from 1 January 2010 to 31 December 2010;

(f)

for programmes referred to in Articles 1 to 16, implement the programme efficiently;

(g)

do not, for the programmes referred to in Articles 1 to 16, submit further requests for other Community contributions for these measures, and have not previously submitted such requests.